Frontlight ResearchEarly access
Congenital heart disease trials in Serbia
1 trial · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationInternational Multicenter Outcomes of Transcatheter Pulmonary Flow Restrictors in Congenital and Acquired Heart Disease
- Where
- Belgrade
- Age
- Up to 3 years
- People
- 150 worldwide
- Run by
- Fondation Hôpital Saint-Joseph
See details and how to joinNCT07791069